CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K/A Event Shareholder vote results
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- 4 Planned sale Director sold 94,906 shares at $8.02 ($761,146)
- 4 Open-market sale Director sold 56,426 shares at $8.02 ($452,537)
- 4 Open-market sale Executive Vice President sold 49,140 shares at $7.58 ($372,481)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Director sold 50,000 shares at $7.59 ($379,500)
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 40,258 shares (option exercise)
Page 6 of 35 · 695 filings